Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorDamascus University
About this trial
This study aims to analyze the effect of Pulmonary Endarterectomy (PEA) on patients' self-confidence in managing their chronic illness.
Patients' confidence (or self-efficacy) will be measured using the following questionnaires: 10-item Perceived Efficacy in Patient-Physician Interaction Scale (PEPPI), Self-Efficacy for Managing Chronic Diseases 6-item Scale (SEMCD-6), Sullivan's cardiac self-efficacy scale 13-items (SCSES). The association between improved confidence and better physical results will be analyzed, such as being able to walk longer (6 mint walk test (6-Minute Walk Test)).
Ultimately, this study will help understanding the psychological side of recovery and might lead to better support programs to help patients feel more capable and live better lives after their operation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
all patients undergoing pulmonary thromboendarterectomy for CTEPH
Able to read and understand the informed consent form and study questionnaires
Disqualifiers
Patients undergoing Balloon Pulmonary Angioplasty (BPA) or receiving only medical therapy (as the focus is on the surgical cohort).
Emergency or salvage PEA procedures (to ensure stable baseline assessment).
Inability to complete the questionnaires due to severe cognitive impairment, psychiatric illness, or language barrier.
Trial population
All patients diagnosed with operable chronic pulmonary thromboembolic pulmonary hypertension undergoing pulmonary thromboendarterectomy
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
10 Participants
are grouped into 1 trial groupGroup A: Patients with CTEPH
Trial outcomes
Primary outcomes
1
10-item Perceived Efficacy in Patient-Physician Interaction Scale (PEPPI)
The scale measures patients perceived self-efficacy. It assesses how confident patients feel in their communication skills with doctors, including explaining health concerns and asking for more information. The scale consists of 10 items where patients rate their confidence on a scale typically from 1 (not at all confident) to 5 (very confident). The total score ranges from 10 to 50, with higher scores indicating higher perceived efficacy.
Time frame
Preoperatively and 6 months postoperatively2
Self-Efficacy for Managing Chronic Diseases 6-item Scale (SEMCD-6)
This scale measures an individual's confidence in their ability to manage tasks and challenges associated with chronic diseases. It assesses self-efficacy related to managing symptoms, treatment, and the impact of chronic diseases on daily life. The scale includes 6 items where individuals rate their confidence on a numerical scale, typically from 1 ("not at all confident") to 10 ("totally confident"). The responses are averaged to produce a final score. The mean score of the 6 items, ranging from 1 to 10, with higher scores indicating higher self-efficacy.
Time frame
Preoperatively and 6 months postoperatively3
Sullivan's cardiac self-efficacy scale 13-items (SCSES)
The SCSES measures a patient's confidence in their ability to manage cardiac-related symptoms and maintain daily functioning despite heart disease. The scale assesses cardiac-specific self-efficacy, including two dimensions - control of symptoms (8 items) and maintaining function (5 items). The scale consists of 13 items. Each item asks, "How confident are you that you know or can..." and is rated by patients from 0 ("not at all confident") to 4 ("completely confident"). The scores are summed for a total score. The total score is the sum of 13 items, ranging from 0 to 52, with higher scores indicating higher cardiac self-efficacy.
Time frame
Preoperatively and 6 months postoperatively4
The 6-minute walk test (6MWT)
The 6MWT measures the functional exercise capacity by assessing the distance a person can walk in six minutes. It evaluates submaximal aerobic capacity, endurance, and overall physical function, particularly useful in cardiopulmonary and chronic disease patients. The patient walks along a flat, straight corridor, ideally 30 meters in length, for 6 minutes. The total distance walked is measured in meters. The test uses a marked corridor with distance markers, a stopwatch, and optionally a pulse oximeter and blood pressure monitor to record physiological responses during the test. Unit of Measurement: Distance walked in meters over 6 minutes.
Time frame
Preoperatively and 6 months postoperativelyLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Damascus University Cardiac Surgery HospitalRecruiting Damascus, Rif-dimashq GovernorateSyria
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov